Amazon and Vertex Pharmaceuticals are solid growth stocks with potential blockbuster drug suzetrigine

From Nasdaq: 2024-11-05 05:53:00

Amazon (NASDAQ: AMZN) is a free cash flow machine, generating $47.7 billion in free cash flow in the last 12 months. CEO Andy Jassy focuses on increasing free cash flow, with opportunities in AWS and e-commerce. Vertex Pharmaceuticals (NASDAQ: VRTX) is a moneymaker and miracle maker, with $11 billion in sales and innovative gene-editing therapies. Suzetrigine could be a blockbuster drug for Vertex. Stock Advisor recommends 10 stocks, excluding Amazon. John Mackey and Keith Speights have positions in Amazon and Vertex.



Read more at Nasdaq: My 2 Favorite Growth Stocks to Buy Hand Over Fist in November